Exabis Library
Welcome to the e-CCO Library!
P719: Identification of differentially expressed genes between AIEC and non-AIEC clinical isolates during in vitro cell infection
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P719: Symptomatic improvement and long-term stability of ulcerative colitis symptoms over 3 years of ozanimod treatment
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P719: Update of a network meta-analysis of efficacy and safety of different intravenous iron compounds in patients with IBD and anaemia
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P720 Recurrent rectovaginal fistula in patients with Crohn’s disease: How can we improve the success rate of graciloplasty? A bi-centric European study in 30 patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P720: Drug survival of first-line biologics in inflammatory bowel disease: large single-centre experience from UR-CARE
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P720: Efficacy of exclusive enteral nutrition for induction and partial enteral nutrition for maintenance of remission in newly diagnosed paediatric and adolescent Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P720: Is there a difference in trough levels and immunogenicity between Crohn’s disease and ulcerative colitis patients treated with infliximab?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P720: Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P720: Use of proton pump inhibitors associated with a markedly increased risk of microscopic colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P721 Early vedolizumab trough levels are associated with induction therapy outcome
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P721: A switch in the prevalence ratio of Crohn's disease vs. ulcerative colitis in Israel between 2003 and 2015 – a report from the epi-IIRN group
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P721: Effect of thalidomide on clinical remission in adult with refractory crohn disease, a multicentre, randomised, double-blind clinical trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P721: Faecal microbiota analysis with body composition and nutritional habits simultaneously amongst Crohn’s disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P721: Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine care
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P721: Treatment of Ulcerative Colitis with OSE-127 (lusvertikimab), a Strict IL-7Rα Antagonist, Non-Cytotoxic Monoclonal Antibody
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P722 Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P722: Compositional differences of gut microbiome using taxonomic profiling in patients with ulcerative colitis after treatment with vedolizumab
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P722: Prediagnostic serum vitamin D levels and risk of inflammatory bowel disease: a pan-European, nested case-control study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P722: Results of the STAR study: management of ulcerative colitis in private practice in france, in the first years following diagnosis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P722: Symptom-based disease trajectories Identify a population of early super-responders in ulcerative colitis achieving complete disease control under targeted therapy
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM